Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam
|ClinicalTrials.gov Identifier: NCT01967654|
Recruitment Status : Withdrawn
First Posted : October 23, 2013
Last Update Posted : August 4, 2015
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Use Cessation||Other: Technical Assistance, training and clinical reminders Other: Referral to Community Health Worker||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2018|
Experimental: Technical assistance, training, plus clinical reminder system
To assess the contextual factors of the intervention settings (district level policies and organizational level characteristics) that may influence tobacco use treatment in CHCs and to inform additional modifications to the proposed implementation strategies.
Other: Technical Assistance, training and clinical reminders
Experimental: TTC + referral to community health workers
To compare the effectiveness and cost effectiveness of two multi component implementation strategies.
Other: Referral to Community Health Worker
- Adherence to tobacco use treatment guidelines [ Time Frame: 4-6 weeks ]To assess the primary outcome of provider adherence to tobacco treatment guidelines, the investigators will conduct patient exit interviews (PEI) (surveys conducted immediately after the patient visit) with 50 smokers pre and 50 postimplementation at each site (1300 in each study period).
- Smoking abstinence [ Time Frame: 6 months ]Using accepted standards for measuring cessation outcomes, all patients who complete a PEI in the post intervention period will be followed prospectively to assess 3 and 6 month 7-day point prevalence abstinence, defined as any smoking (even a puff) in the past 7 days. Surveys will be conducted in person and smoking abstinence will be validated using carbon monoxide (CO) monitoring with abstinence defined as a CO<10ppm.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01967654
|Institute of Social and Medical Studies|
|Principal Investigator:||Donna Shelley, MD, MPH||NYU School of Medicine|